Stock Screener App

Gratuito - Play StoreApp Store

Installare Installare

Dow:

Nasdaq:

S&P 500:

RDHL

$0.38786.91%-0.0288

Dopo l'orario di chiusura: 0.39+0.00 +0.57%

Redhill Biopharma Ltd Adr (RDHL)

Date: O: H: L: C: Vol:

Redhill Biopharma Ltd Adr Borsa (RDHL) Ultime notizie

Drug rights return to RedHill Biopharma (RDHL) as Hyloris agrees to a $200,000 break-up fee. - Stock Titan

RedHill Biopharma Secures $2.9M NCI Grant for Opaganib and CAR T-Cell Therapy in Multiple Myeloma - Kalkine Media

$2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma - PR Newswire

Each depositary share represents 10,000 ordinary shares at RedHill Biopharma (RDHL). - Stock Titan

Nasdaq gives RedHill Biopharma (NASDAQ: RDHL) more time to clear its $1 bid-price hurdle - Stock Titan

Form 4 RedHill Biopharma Ltd. For: 6 October By Investing.com - Investing.com Canada

Form 4 RedHill Biopharma Ltd. For: 6 October By Investing.com - Investing.com UK

RedHill Biopharma closes $19.4M private placement - scanx.trade

Redhill Biopharma Ltd (NASDAQ: RDHL) Share Price, RDHL Stock News, RDHL Share Price & Updates - Kalkine

RedHill Biopharma Ltd. (RDHL) Stock Price, News, Quote & History - Yahoo! Finance Canada

Small Caps Test Their 200-Day Line as Yields Grind Higher and Earnings Season Stirs - GlobeNewswire

RedHill Biopharma Reshapes GI Portfolio With Rebyota, Clenpiq Deal and Talicia Sale - The Globe and Mail

Redhill Biopharma Ltd (NASDAQ: RDHL) Share Price, RDHL Stock News, RDHL Share Price & Updates - kalkine.ca

A 70% Talicia stake sale brings RedHill Biopharma (RDHL) cash plus potential sales milestone payments. - Stock Titan

Continuing-operations revenue fell to zero at RedHill Biopharma (RDHL), while its first-half loss widened. - Stock Titan

RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results - PR Newswire

One dose showed over 70% success preventing repeat infections from C. diff bacteria. RedHill acquired its rights. - Stock Titan

RedHill Biopharma stock jumps 95% after $18M Talicia divestment - scanx.trade

Press Release: RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results - Moomoo

RDHL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

RedHill Biopharma Buys Global Rights to Two Established GI Drugs from Ferring - BioBuzz

RedHill Biopharma Buys Global Rights to Two Established GI Drugs from Ferring - BioBuzz

RedHill (RDHL) Acquires Rebyota and Clenpiq Commercialization Rights for $12M Upfront. Can Sales Outpace Royalties? - Yahoo Finance

Redhill Biopharma Ltd. - ADR Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research

The trading volume of these stocks is deviating from the norm in today's session. - ChartMill

RedHill acquires rights to two GI drugs from Ferring for $12M - Investing.com Nigeria

RedHill acquires rights to two GI drugs from Ferring for $12M - Investing.com Australia

RedHill acquires rights to two GI drugs from Ferring for $12M - Investing.com India

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq® - Barchart.com

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq® - PR Newswire

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq® - Stock Titan

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq - Nasdaq

Redhill Biopharma Ltd. - ADR Key Financial Ratios – Valuation, Profitability & More - Value Research

Redhill Biopharma Ltd. stock Analysis: Overbought Signals and Key Levels to Watch - The Cryptonomist

RedHill Biopharma Sells Talicia to Apotex for $18M Upfront Plus $35M in Potential Milestones - kalkinemedia.com

RedHill Biopharma (RDHL) sells Talicia stake for upfront pay, milestone upside - Stock Titan

Redhill Biopharma Stock Doubles In One Session — Here's Why - Yahoo Finance

RedHill Biopharma jumps on $18 million Talicia sale to Apotex - Quiver Quantitative

RedHill Biopharma (NASDAQ: RDHL) Soars to $1.60 - Monetizes Talicia Stake in $18 Million Cash Deal With Apotex - Investorideas.com

RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities - PR Newswire

RedHill Biopharma jumps on $18 million Talicia sale to Apotex - Quiver Quantitative

RDHL Stock Volatility Draws Trader Focus As Biotech Reprices - StocksToTrade

RDHL Stock Draws Trader Focus As Volatility Spikes - StocksToTrade

RedHill Biopharma Shares Surge as Talicia Sale to Apotex Brings $18 Million Upfront - finance.biggo.com

Redhill Biopharma Ltd. - ADR Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Can RedHill Biopharma (NASDAQ:RDHL) Show Commercial Progress Today? - Kalkine Media

RedHill Biopharma (RDHL) investors back all AGM resolutions in 2026 - Stock Titan

RedHill Biopharma (NASDAQ: RDHL) adjourns AGM after quorum shortfall - Stock Titan

Redhill Biopharma (RDHL) Advances 3.4% as Shares Test Key Resistance at $0.70 - MACD Signal Stocks - careplusvn.com

Redhill Biopharma (RDHL) Edges Higher: Penny Stock Approaches Key Resistance at $0.68 - Exhaustion Gap - careplusvn.com

Simile a RDHL

YCBD$0.38271.34%

PRFX$0.73012.68%

SBFM$2.9312.01%

GELS$0.49013.14%